Related Experiment Videos
Initiation codon mutation as a cause of alpha thalassemia
The Journal of Biological Chemistry
|October 25, 1984
Summary
Researchers discovered a new alpha-thalassemia mutation in Sardinian patients. This genetic lesion in the alpha 2-globin gene prevents normal hemoglobin production, impacting red blood cell health.
Area of Science:
- Genetics
- Molecular Biology
- Hematology
Background:
- Alpha-thalassemia is a genetic blood disorder characterized by reduced or absent synthesis of alpha-globin chains.
- Nondeletion alpha-thalassemia results from mutations affecting alpha-globin gene expression or stability, rather than gene deletion.
- Hemoglobin H disease is a severe form of alpha-thalassemia.
Purpose of the Study:
- To identify the genetic basis of nondeletion alpha-thalassemia in Sardinian patients.
- To characterize a novel mutation in the alpha-globin gene responsible for thalassemia.
- To develop a diagnostic method for the identified mutation.
Main Methods:
- Cloning and sequence analysis of alpha-globin genes.
- Analysis of globin mRNA levels.
- Restriction fragment length polymorphism (RFLP) analysis using NcoI enzyme.
Main Results:
- A new mutation changing the initiation codon (ATG to ACG) in the alpha 2-globin gene was identified.
- This mutation abolishes the function of the alpha 2-globin gene and decreases its mRNA output.
- The mutation was detectable by NcoI restriction analysis in genomic DNA.
- Six out of seven Sardinian patients with nondeletion alpha thalassemia carried this specific mutation.
Conclusions:
- A novel initiation codon mutation in the alpha 2-globin gene is a frequent cause of nondeletion alpha-thalassemia in Sardinia.
- This mutation significantly impairs alpha-globin synthesis, contributing to thalassemia.
- Restriction analysis with NcoI provides an effective diagnostic tool for this specific thalassemia lesion.